Increasingly Complex ACS Patients: Culprit Only, Complete Percutaneous Revascularization or CABG?

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - J&J; Novartis
• Grant Support/Research Contract - Abbott; Amgen